With No Way to Identify Omicron and Delta Patients, US Doctors Struggle With Treatment Decisions

There is no approved test to determine which variant each patient has, and that makes treatment nearly impossible to tailor as supplies run low.There is no approved test to determine which variant each patient has, and that makes treatment nearly impossible to tailor as supplies run low.Coronavirus Omicron Variant, Coronavirus (2019-nCoV), Coronavirus Delta Variant, Tests (Medical), Centers for Disease Control and Prevention, Eli Lilly and Company, GlaxoSmithKline PLC, Regeneron Pharmaceuticals Inc, United StatesRead More

Leave a Reply

Your email address will not be published.